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Abstract 
 
 
Extracellular signal-regulated kinase (ERK), is a member of the mitogen-
activated protein kinase (MAPK) family of serine/threonine protein kinases. 
Functioning as intracellular signaling molecules, they are responsible for 
multiple extracellular signals transduction into diverse intracellular responses 
through transcriptional and post-translational regulations. ERK is proposed to 
be a molecular substrate linked to several nociceptive-related processes such 
as central sensitization, corresponding to a drastical increase on synaptic effi-
cacy of neurons involved in nociceptive-transmission, their threshold reduc-
tion, pain signals enhancement, thus contributing to various chronic pain 
syndromes. Regulation of those pathways occurs primarily by MAPKs 
through central and peripheral mechanisms, whereby inhibition could provide 
significant anti-nociceptive effects. Although neurobiological mechanisms 
underlying pain pathways are extensively studied, many details remain un-
clear. 
 
Herein, an immunohistochemical study was designed to investigate whether 
phosphorylated extracellular signal-regulated kinase (pERK) is found among 
neurons in nociceptive-related brain areas following mechanical noxious 
stimuli (pinch) applied to the tail and right hindpaw of three male Swiss-
Webster B6 mice. Administration of ketamine was used for anesthetic pur-
poses, while only one subject was viable for further experiments. Coronal 
sections were incubated on primary antibody rabbit anti-phospho-p44/42 
ERK; 1:250, and immunostained using biotinylated donkey anti-rabbit sec-
ondary antibody; 1:500. Confocal immunofluorescence microscopy revealed 
that phospho-ERK immunopositive cells were activated and expressed in 
integral amygdala regions of one brain sample, with higher intensity on the 
laterocapsular division of central amygdala. Accumulating evidences sug-
gests pERK expression in amygdala to be responsible for pain modulation 
and emotional aspects. However, absence of control subjects leads to paucity 
of evidences, where no definitive conclusion can be drawn. Molecular mech-
anisms of pain and modulation by the amygdala associated with pERK re-
quire further elucidation. 
Keywords: Amygdala, Extracellular signal-regulated kinase (ERK), Mitogen-activated pro-
tein kinase (MAPK), Nociceptive, Pain 
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Abbreviations
  
 
 
BDNF – Brain derived neurotrophic factor 
CALCRL – Calcitonin receptor-like receptor 
CeA – Central nucleus of the amygdala 
CeLC – Laterocapsular division of the central nucleus of the amygdala 
CGRP – Calcitonin gene-related peptide  
CREB – cAMP response element-binding protein 
ERK – Extracellular signal-regulated kinase 
MAPKs – Mitogen-activated protein kinases 
NK1 – Neurokinin-1 receptor 
PAG – Periaqueductal grey 
RVM – Rostral ventromedial medulla 
SCDH – Spinal cord dorsal horn neurons 
SP – Substance P 
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1 Introduction 
 
Nociception is a term used to describe the ability of an organism that 
possess a central and peripheral nerve system, to feel pain. The nociceptive 
system is defined to have four intrinsically steps; Transduction, transmis-
sion, modulation and perception. Despite the fact that there is not an iso-
lated brain area defined to be unique for pain roles, each step occurs in 
polymorphous regions of the body and is critical for pain pathways. Thus, 
pain results from a combination of scattered group of structures, like the 
somatosensory cortex, associated with the sensory-discriminative proper-
ties (location and intensity) and others, like the anterior cingulate gyrus, 
insular cortex and amygdala, related to the emotional aspects of pain. (Ap-
karian et al., 2005). 
 
The nervous system has evolved to sense a broad range of stimuli that 
could propose danger, developing in this manner a defense mechanism 
against harmful agents. Nociceptors are key points in this system, as they 
enable detection of noxious stimuli linked to distinct receptors and react in 
response to those substances. Nonetheless, when this system does not work 
properly, it may enhance pain signals (pain sensitization), resulting in un-
bearable discomfort. Neuropathic and chronic pain occurs when physical 
damage or diseases arises in peripheral nerves eliciting symptoms such as 
allodynia, when a normal innocuous stimuli is perceived as very painful, or 
such as hyperalgesia, when a not very painful stimuli, is sensed with high-
er intensity. (Apkarian et al., 2005). 
 
   “Pain is personal and subjective, is affected by mood and psychosocial 
factors, and demonstrates tremendous individual variation” (National Insti-
tutes of Health 2001). Worldwide, pain is considered a problematic health 
issue estimated to affect at least 20% of global population in adults suffer-
ing from a series of pain conditions with 10% newly diagnosed cases each 
year. (National Institutes of Health 2001) 
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1.1 MAPK/ERK  
 
The mitogen-activated protein kinase (MAPK) is a highly conserved 
family of serine/threonine protein kinases, characterized as intracellular 
signaling molecules, responsible for the transduction of multiple extracel-
lular signals (neurotransmitters, hormones, growth factors, etc.) into varied 
intracellular responses through transcriptional and post-translational regu-
lations. (Widmann et al., 1999) To date, three dominant members of this 
family were identified; Extracellular signal-regulated kinase (ERK), c-Jun 
N-terminal kinase (JNK) and p38. All members have being defined to have 
distinct signaling cascades that contributes to pain sensitization (Seger., et 
al 1995). 
 
The first member identified, was extracellular signal-regulated kinase 
(ERK), described to prosecute essential cellular functions such as; differ-
entiation, proliferation, apoptosis, stress and inflammatory responses, 
among others (Widmann et al., 1999). Activation of ERK occurs with an 
extensive influx of calcium ions, membrane depolarization and phosphory-
lation of Thr and Tyr regulatory residues through specific upstream 
MAPK/ERK kinase (MEK). (Seger., et al 1995). In this manner, pERK is 
strongly related to nociceptive mechanisms, but seems to be highly in-
volved in neuronal plasticity, analogous to long-term potentiation, sharing 
similarities with learning and memory processes (Ji et al., 2003).  
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1.2 ERK and pain 
 
Phosphorylation of extracellular signal-regulated kinase (pERK) is tight-
ly connected to noxious stimuli (thermal/mechanical), as well as it’s ex-
pression is increased through activation of high-threshold C-fiber and Aδ-
fiber, where intensity and duration are determinant factors. (Baba., et al 
1999; Zhuang., et al 2015). Recent experiments using distinct stimulation 
methods such as; electrical (Fukui., et al 2007), mechanical (Huma., et al 
2015), and itch (Jiang., et al 2015), have shown pERK immunopositive 
cells activation in regions such as; Cerebral cortex (Takamura., et al 2008), 
RVM and locus coerulus (Imbe., et al 2004), microglia and astrocytes 
(Zhuang., et al 2015), demonstrating correlation with nociceptive-related 
processes, like peripheral sensitization (Dai., et al 2002), peripheral in-
flammation (Imbe., et al 2005) (Imbe., et al 2008), allodynia/neuropathic 
pain (Zhuang., et al 2015) and hypersensitivity (Obata., et al 2004) (Baba., 
et al 1999). 
 
When primary afferent nociceptors are stimulated and reach threshold, 
they form what is called a “glutamatergic synapse” thereby glutamate, an 
excitatory neurotransmitter, is released from presynaptic neurons, binding 
on postsynaptic neurons to specialized receptors; Ionotropic 
(NMDA/AMPA/Kainate) (Krapivinsky et al., 2003) and metabotropic 
(mGlur) (Karim et al., 2001). Subsequent studies have proved that NMDA 
receptors are the main target of protein kinases playing two-sided roles, as 
an upstream activator, coupling straightforward or diffusely through PKA 
and PKC to ERK activation, and as a downstream target, due to the fact 
that ERK, PKA and PKC are able to phosphorylate NMDA receptors en-
hancing current flow and accelerating it’s kinetics (Krapivinsky et al., 
2003). Specifically to amygdala, protein kinases involved in nociceptive 
events are PKA and ERK but not PKC. (Fu et al., 2008). 
 
Neuropeptides and their respective receptors; Substance P (SP) (Choi et 
al., 2005) and receptor G-protein coupled neurokinin-1 (NK1) (Polgár et 
al., 2007), calcitonin gene-related peptide (CGRP) and calcitonin receptor-
like receptor (CALCRL) (Han et al., 2005), brain derived neurotrophic 
factor (BDNF) and receptor tropomyosin receptor kinase B (TrkB) (Pezet 
et al., 2002), are also critical for nociceptive transmission, well-established 
to potentiate nociceptive effects by playing critical roles in multiple path-
ways responsible for ERK activation. Phosphorylated ERK (pERK) there-
  4 
upon travels from the cytoplasm to the nucleus, activating Rsk2, conse-
quently phosphorylating the transcription factor CREB on Serine 133 
(Xing., et al 1996) resulting in gene transcription and synthesis of pro-
inflammatory and pro-nociceptive mediators that enhance and prolong 
pain in a transcriptional regulation manner, implicating in the induction 
and maintenance of inflammatory pain related to late effects of central 
sensitization. Though, other factors contributes to early and acute central 
sensitization in a post-translational regulation manner, as upregulation of 
aforesaid glutamatergic receptors and downregulation of  Kv4.2 potassium 
channels (Hu et al., 2006).  
Inhibition of MAPK/ERK pathways resulted in neuropathic pain relief 
in several animal models (Weiya et al., 2005). 
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1.3 ERK expression in amygdala 
 
The amygdala is localized in the medial temporal lobe with an almond 
shape structure, is part of the limbic system and plays an essential role in 
emotions derived from sensory stimulus, learning and memory. Previous 
studies have elicited the amygdala to be responsible for linking external 
stimuli to defense responses and to play a fundamental role in affective 
disorders such as depression and anxiety (LeDoux, 2003). 
 
Composed of different nuclei such as; lateral, basolateral, accessory ba-
sal, medial and central nucleus, is well known for being a neural center for 
pain modulation, especially the laterocapsular division that has been char-
acterized as the nociceptive amygdala (Neugebauer et al., 2004). The 
amygdala receives nociceptive inputs in a direct manner from spinal cord 
and brainstem, in an indirect manner via the lateral-basolateral amygdala 
circuitry from thalamus and cortex, where highly processed polymodal 
information is gathered, a mechanism hypothesized to be involved in how 
the amygdala attaches emotional significance to painful events (LeDoux, 
2003). The amygdala appears to be involved in dual nociceptive pathways, 
ascending via the spino-parabrachio-amygdaloid pathway, and descending 
via amygdala-PAG-RVM–spinal cord, where it plays two-sided roles such 
as inhibitory and facilitatory (pain enhancement/diminishment). 
(Neugebauer et al., 2004) The question whether pERK activation in amyg-
dala modulates either one of them or both, needs to be further elucidated.  
 
Using the formalin pain model, a previous study has confirmed ERK 
activation in the CeLC. (Carrasquillo et al., 2007) Inhibition of this path-
way exhibited successful antinociceptive effects. (Cruz et al., 2005). Dis-
tinct signaling pathways such as PKA and PKC were suggested to act in 
concert in order to phosphorylate and activate ERK in amygdala neurons 
(Ji., et al 2003) However it was proved that in the amygdala, PKA, that is 
activated by neuropeptide receptors, and ERK, activated by multiple glu-
tamate receptors, respectively, are responsible for pain transmission and 
modulation. (Fu et al., 2008) Nonetheless, how ERK contributes to synap-
tic transmission and plasticity in the CeLC remains unknown. 
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2 Materials and Methods  
 
2.1 Animals 
 
Experiments were performed in 3 adult (2-4 months old) Male Swiss-
Webster B6 mice (23-25g) (Jax Stock 008069) kept in a 12-h light-dark 
cycle, at 22 ± 0.5°C. Food and water were available ad libitum.  
All animal procedures were performed in accordance with the guidelines 
and approved by the local Swedish ethical committee (C248/11, C157/11, 
C366/12 Uppsala Animal Ethics Committee, Jordbruksverket). 
2.2 Nociceptive stimulation 
 
All subjects were transferred from the animal facility and allowed 30 
min for acclimation to the laboratory. The type of noxious stimulus chosen 
was the mechanical (pinch) according to a previous study (Polgár et al., 
2007) in which the most numerous pERK positive cells were obtained.  
 
Repeated pinching was applied to the right hindpaw and to the tail for 
one minute period interval. Immediately after the stimulus, animals were 
deeply anesthetized with ketamine (0.025 ml/g body weight), the time 
from onset of anesthesia to perfusion was approximately 5 minutes in all 
individuals. Mice were then perfused through the ascending aorta on the 
left ventricle, with physiological saline (PBS) followed by ice-cold phos-
phate-buffered 4% paraformaldehyde (0.1M, pH 7.4). A peristaltic perfu-
sion pump was set for 15min at a flow rate of 5-6 ml/min.  
 
Whole brains were dissected and post-fixed for cryoprotection in 30% 
sucrose for 48 h at 4°C. Frozen coronal sections were cut 35µm-thick on a 
cryostat (CRYOCUT 1800, Reichert-Jung). 
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2.3 Immunohistochemistry procedure 
 
Coronal sections were collected as one set and processed for immuno-
histochemistry procedure through washing with phosphate-buffered saline 
(PBS, 0.1M) 3 x 5 min, then blocked in 1.5% goat serum and 0.1% Triton 
X-100 with 0.1M PBS for 45 min. Sections were then incubated with the 
primary antibody (rabbit anti-phospho-p44/42 ERK; 1:250; Catalog num-
ber 9101S, Cell Signaling Technology) for a period of 48 hours at 4°C.  
 
Sections were rinsed 3 x 5 min (PBS, 0.1M) following incubation with 
biotinylated donkey anti-rabbit secondary antibody (1:500; Catalog num-
ber R37118, Alexa Fluor 488) for 2 hours at room temperature. During 
incubation periods, sections were continuously agitated. After rinsing, 
sections were mounted on glass slides and coverslipped with glycerol 
mounting medium. 
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3 Results  
 
The present results are from one individual only, as after anesthesia ad-
ministration, the other two subjects turned unviable for further experiment 
steps. Using specific antibodies for pERK, coronal sections from the stim-
ulated animal were immunostained and showed that the pinch applied to 
the right hindpaw and to the tail evoked ERK phosphorylation visualized 
by confocal immunofluorescence microscopy (Olympus, BX61WI) that 
revealed phospho-ERK immunopositive cells activation and expression in 
amygdala, more intensely on laterocapsular division, followed by mechan-
ical noxious (pinch) stimuli. (Figure 1) 
Figure 1: Coronal sections from subject where mechanical noxious stimulus (pinch) evoked ERK 
phosphorylation in integral amygdala regions, with a clearly greater intensity on laterocapsular division.  
150μm and 70μm respectively. CeL: Lateral subdivision of central nucleus. CeC: Capsular subdivision 
of central nucleus. 
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4 Discussion  
 
Ketamine was administered for anesthetic purposes (Klein., et al 
2007). Previous studies have elucidated the interference of anesthesia ef-
fects on immunohistochemical detection (Takamura., et al 2008) and 
ERK activation (Tochiki., et al 2015). The results obtained confirmed 
those facts, as two subjects turned unviable for further experiments, 
while only one individual proceeded to the next steps of immunohisto-
chemistry analyses, where confocal immunofluorescence microscopy 
(Olympus, BX61WI), revealed that phospho-ERK immunopositive cells 
were activated and expressed in amygdala, (more intensely on laterocap-
sular division) followed by mechanical noxious (pinch) stimuli. (Figure 
1). 
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5 Conclusion  
 
The present study indicated ERK characterization with incisive pathways. Re-
sults confirmed pERK expression in the amygdala and elucidated it’s involve-
ment in nociceptive behavior. However, absence of control subjects leads to pau-
city of evidences, where no definitive conclusion can be drawn.  
To further clarify the molecular mechanisms of pain and modulation by the 
amygdala associated with phosphorylated extracellular signal-regulated kinase 
(pERK), supplementary studies using modern techniques are desirable. 
  11 
6 Future perspectives 
 
Optogenetics is a modern technique more suitable for such experiment, due to 
advantages of directly stimulating and light-controlling genes in specific neurons 
of interest, leading to more clear results where more precisely conclusions can be 
drawn. 
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